戻る Agenda
Parallel Session 8A: Supply Chain & Sample Management
Session Chair(s)
Joerg Garbe, PhD, MSc
Global Quality Manager & Policy Lead
F. Hoffmann-La Roche Ltd, Switzerland
Representative Invited
Egyptian Drug Authority, Egypt
This Session will explore the global trend of using a Reliance-based waiver for in-country testing. Regulators will share their practical experiences with risk-based surveillance testing to replace import/registration testing. The goal of this session is to support regulators in the MENA region in optimising their testing systems to avoid waste of resources and ensure no delay of drug supply to patients.
Speaker(s)
Risk-based Surveillance Testing in Serbia and How it Complements Anti-Counterfeit Activities
Pavle Zelic
Medicines and Medical Devices Agency of Serbia (ALIMS), Serbia
International Cooperation, European Integrations and Public Relations
Panel Discussion with Q&A
Agnes Chan
Health Sciences Authority Singapore, Singapore
Regulatory Consultant with the Pharmaceuticals & Biologics Branch